Hamed Shahbazi, Director at Aequus Pharmaceuticals, holds 15.35M shares in WELL Health Technologies Corp (Ticker: TSE:WELL), holds 30.80M shares in HEALWELL AI (Ticker: TSE:AIDX), holds 5.29M shares in BBTV Holdings, Inc. (Ticker: TSE:BBTV). Most recently, Hamed Shahbazi Bought ― shares of WELL Health Technologies Corp on May 24, 2025 for an estimated value of 14.69K.
Hamed Shahbazi latest transaction was an Informative Buy of C$14.69K.
What was Hamed Shahbazi's most profitable transaction?
Hamed Shahbazi’s most profitable transaction was an Informative Buy of TSE:WELL stock on May 18, 2017. The return on the trade was 547.70%.
What is Hamed Shahbazi's role in Aequus Pharmaceuticals?
Hamed Shahbazi's role in Aequus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.